TIMI Study Finds New Class of Anti-Clotting Drug Reduced Bleeding Events Compared with Standard of Care in Patients with Atrial Fibrillation (IMAGE)

Brigham and Women's Hospital

TIMI Study Finds New Class of Anti-Clotting Drug Reduced Bleeding Events Compared with Standard of Care in Patients with Atrial Fibrillation

Caption

Researchers from Brigham and Women’s Hospital, a founding member of the Mass General Brigham healthcare system, evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the AZALEA-TIMI 71 Study.

Credit

Brigham and Women's Hospital

Usage Restrictions

N/A

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.